These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28281534)

  • 1. In the news: ISC 2017 - getting the heads-up on stroke.
    Wood H
    Nat Rev Neurol; 2017 Apr; 13(4):194. PubMed ID: 28281534
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
    Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Lancet Neurol; 2017 Apr; 16(4):301-310. PubMed ID: 28238711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
    Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KS;
    N Engl J Med; 2016 Jul; 375(1):35-43. PubMed ID: 27160892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial: rationale and design.
    Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Held P; Jonasson J; Minematsu K; Molina CA; Wong LK
    Int J Stroke; 2015 Dec; 10(8):1304-8. PubMed ID: 26311628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
    Easton JD; Aunes M; Albers GW; Amarenco P; Bokelund-Singh S; Denison H; Evans SR; Held P; Jahreskog M; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Circulation; 2017 Sep; 136(10):907-916. PubMed ID: 28655834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter by Moris et al Regarding Article, "Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)".
    Moris D; Bakoyiannis C; Avgerinos E
    Stroke; 2017 Apr; 48(4):e110. PubMed ID: 28209714
    [No Abstract]   [Full Text] [Related]  

  • 7. Response by Wang and Johnston to Letter Regarding Article, "Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)".
    Wang Y; Johnston SC
    Stroke; 2017 Apr; 48(4):e111. PubMed ID: 28209715
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of ticagrelor with clopidogrel on high on-treatment platelet reactivity in acute stroke or transient ischemic attack (PRINCE) trial: Rationale and design.
    Wang Y; Lin Y; Meng X; Chen W; Chen G; Wang Z; Wu J; Wang D; Li J; Cao Y; Xu Y; Zhang G; Li X; Pan Y; Li H; Liu L; Zhao X; Wang Y;
    Int J Stroke; 2017 Apr; 12(3):321-325. PubMed ID: 28381198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke.
    ; van Gijn J; Algra A; Kappelle J; Koudstaal PJ; van Latum A
    N Engl J Med; 1991 Oct; 325(18):1261-6. PubMed ID: 1922220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
    Johnston SC; Amarenco P
    N Engl J Med; 2016 Oct; 375(14):1395. PubMed ID: 27705253
    [No Abstract]   [Full Text] [Related]  

  • 12. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
    Landman GW; Kleefstra N
    N Engl J Med; 2016 Oct; 375(14):1394. PubMed ID: 27705254
    [No Abstract]   [Full Text] [Related]  

  • 13. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
    Čulić V
    N Engl J Med; 2016 Oct; 375(14):1394-1395. PubMed ID: 27705255
    [No Abstract]   [Full Text] [Related]  

  • 14. Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes.
    Wang Y; Pan Y; Zhao X; Li H; Wang D; Johnston SC; Liu L; Meng X; Wang A; Wang C; Wang Y;
    Circulation; 2015 Jul; 132(1):40-6. PubMed ID: 25957224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Stroke; 2017 Sep; 48(9):2610-2613. PubMed ID: 28701574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antiplatelets reduce microembolic signals in patients with transient ischemic attack and minor stroke: subgroup analysis of CLAIR study.
    Lau AY; Zhao Y; Chen C; Leung TW; Fu J; Huang Y; Suwanwela NC; Han Z; Tan KS; Ratanakorn D; Markus HS; Wong KS;
    Int J Stroke; 2014 Oct; 9 Suppl A100():127-32. PubMed ID: 23489888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.
    Diener HC; Bogousslavsky J; Brass LM; Cimminiello C; Csiba L; Kaste M; Leys D; Matias-Guiu J; Rupprecht HJ;
    Lancet; 2004 Jul 24-30; 364(9431):331-7. PubMed ID: 15276392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.
    Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Stroke; 2017 Sep; 48(9):2480-2487. PubMed ID: 28720658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke?
    Dippel DW; Van Kooten F; Leebeek FW; van Vliet HH; Mehicevic A; Li SS; Koudstaal PJ
    Cerebrovasc Dis; 2004; 17(4):296-302. PubMed ID: 15026612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.